An Invitation to a CME Program sponsored by the University of Tennessee College of Medicine Chattanooga in Co-Sponsorship with the American Academy of Developmental Medicine & Dentistry, and Joint Sponsorship with the EP Foundation for Education, Inc.
Participate Live Online with our Distinguished Faculty
New Innovative Treatments for Spasticity Encountered in Persons with Cerebral Palsy
There is a clear need for an educational activity which addresses new innovative approaches to the treatment of spasticity encountered in persons with cerebral palsy. Review of scientific peer-reviewed literature as well as clinical experience demonstrate a correlation between severity of spasticity and high morbidity and mortality seen in individuals with cerebral palsy and other developmental disabilities.
Both primary care as well as specialist physicians, and also nurses, physical therapists, and other health professionals need to have a better understanding of current state-of-the-art approaches to the treatment of spasticity encountered in persons with cerebral palsy, which can in turn lead the health professional to a more rational selection of treatment/management strategies and better outcomes for their patients
Conference Goal
The overall goal of this conference is to improve clinical knowledge, skills, and competency of those health professionals that provide services to adults and children with cerebral palsy who also demonstrate spasticity.
Educational Objectives
Upon completion of this educational activity, participants will be able to:
Discuss the use of intrathecal baclofen in the treatment of spasticity encountered in persons with cerebral palsy.
Discuss the use of botulinim toxin in the treatment of spasticity encountered in persons with cerebral palsy.
Supported by an unrestricted educational grant from Allergan Pharmaceuticals, Inc.
Registration
There is no registration fee to participate in this program.
Who Should Attend
Pediatricians, Internists, Family Practitioners, Neurologists, Nurses, Physical Therapists, Occupational Therapists.
Accreditation Statement
This activity has been planned and implemented in accordance with the "Essential Areas and their Elements" of the Accreditation Council on Continuing Medical Education, through the co- sponsorship of the UTCOM-Chattanooga and the American Academy of Developmental Medicine and Dentistry (AADMD).
The UTCOM-Chattanooga is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.
The American Academy of Developmental Medicine & Dentistry is accredited by the Medical Society of New Jersey (MSNJ) to provide continuing education for physicians.
Credit Designation Statement
UTCOM-Chattanooga designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Instructions to Receive Credit
In order to receive AMA PRA Category 1 Credits™, physicians must attend the entire 2.5 hour conference, complete the CME Evaluation Form. These forms will be made available at the time of the conference online.
Disclosure Policy
UTCOM-Chattanooga requires that faculty participating in a CME activity disclose to the audience any relationship with a pharmaceutical or equipment company that might pose a potential, apparent, or real conflict of interest with regard to their contribution to the program. This information will be made available to the audiences prior to the presentation.
Activity Co-Directors
Chris Prater MD
Associate Clinical Professor of Medicine
Department of Family Medicine
UT College of Medicine-Chattanooga
Rick Rader MD
President,
American Academy of Developmental Medicine & Dentistry
Editor-in-Chief, EP Magazine
Philip B. May MD
Clinical Associate Professor of Medicine, UMDNJ-Robert Wood Johnson Medical
School
Assistant Medical Director,
Hunterdon Developmental Center
Director of Medical Education,
American Academy of Developmental Medicine and Dentistry
